TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25800768

Group type: EXPERIMENTAL
Intervention: Early palliative care (PC) consultation, structured PC telehealth nurse coaching sessions (once per week for six sessions), and monthly follow-up
Number of subjects: 207

Group type: COMPARATOR
Intervention: Delayed palliative care (PC) consultation, structured PC telehealth nurse coaching sessions (once per week for six sessions), and monthly follow-up
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Early palliative care (PC)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Delayed palliative care (PC)
Number of subjects: 207
Study: 23684814

Group type: EXPERIMENTAL
Intervention: Double-barrel approach (DBA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classic canine fossa puncture (CFP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both DBA and CFP
Number of subjects: 0
Study: 21412231

Group type: COMPARATOR
Intervention: Lorcaserin (20 mg)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Lorcaserin (supratherapeutic doses)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Lorcaserin (all doses)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Zolpidem (15 and 30 mg)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Ketamine (100 mg)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 19536092

Group type: EXPERIMENTAL
Intervention: Oxaliplatin and capecitabine treatment
Number of subjects: 91
Study: 17825709

Group type: EXPERIMENTAL
Intervention: Prophylactic hemodialysis
Number of subjects: 82
Study: 14996351

Group type: EXPERIMENTAL
Intervention: peginterferon alpha 2a (pegIFNalpha 2a)
Number of subjects: 412

Group type: COMPARATOR
Intervention: IFNalpha 2b/RBV
Number of subjects: 412
Study: 11398690

Group type: EXPERIMENTAL
Intervention: Closed suction system (CS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Open suction system (OS)
Number of subjects: 10
Study: 9580448

Group type: EXPERIMENTAL
Intervention: Metamizol 2 g
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Metamizol 1 g
Number of subjects: 253

Group type: COMPARATOR
Intervention: Ibuprofen 600 mg
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study: 10179576

Group type: EXPERIMENTAL
Intervention: Back-propagation neural network
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discriminant analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster analysis
Number of subjects: 0
Study: 1778353

Group type: EXPERIMENTAL
Intervention: Active policy with either insulin or sulphonylurea aiming to reduce fasting plasma glucose to under 6 mmol/l
Number of subjects: 5100

Group type: COMPARATOR
Intervention: Diet policy
Number of subjects: 5100

Group type: EXPERIMENTAL
Intervention: Tight control aiming for less than 150/85 mm Hg with either an angiotensin‐converting enzyme inhibitor or a Beta‐blocker
Number of subjects: 5100

Group type: COMPARATOR
Intervention: Less tight control aiming for less than 200/105 mm Hg
Number of subjects: 5100

Group type: EXPERIMENTAL
Intervention: Surrogate endpoints
Number of subjects: 5100
Study: 6756327

Group type: EXPERIMENTAL
Intervention: PEEP (10 cm H2O)
Number of subjects: 83

Group type: COMPARATOR
Intervention: No PEEP (zero end-expiratory pressure)
Number of subjects: 83
Study: 31927343

Group type: EXPERIMENTAL
Intervention: CVT‐301 84 mg
Number of subjects: 408

Group type: COMPARATOR
Intervention: Observational cohort (OC) receiving oral standard of care
Number of subjects: 408
Study: 31105006

Group type: EXPERIMENTAL
Intervention: Simulation-based training
Number of subjects: 47
Study: 29228795

Group type: EXPERIMENTAL
Intervention: Vitamin A eye ointment (VAEO) administered every 6 hr for 5 days
Number of subjects: 38

Group type: COMPARATOR
Intervention: Moist chamber (MC) with polyethylene cover replaced every 12 hr
Number of subjects: 38
Study: 26404953

Group type: EXPERIMENTAL
Intervention: Combination of 0.5 μg calcitriol, 75 mg acetylsalicylic acid, and 1250 mg calcium carbonate (n = 209)
Number of subjects: 1107

Group type: COMPARATOR
Intervention: Placebo (n = 218)
Number of subjects: 1107

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for nonsmokers
Number of subjects: 1107

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for current smokers
Number of subjects: 1107
Study: 24121464

Group type: EXPERIMENTAL
Intervention: Nurse-led delirium rounds with unit champions, average duration 25.54 min (SD = 13.18)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Multiple strategies and local opinion leader/unit champion
Number of subjects: 192
Study: 22537957

Group type: EXPERIMENTAL
Intervention: Ulinastatin treatment (1.0×10(4) U/kg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 19995589

Group type: EXPERIMENTAL
Intervention: 50% ethanol for 30s, 70% ethanol for 30s, 80% ethanol for 30s, 95% ethanol for 30s, 100% ethanol for 30s (Group 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Adper Scotchbond Multi‐Purpose (Control Group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ethanol dehydration with 15s for each solution (Group 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 100% ethanol applied in seven 30s steps (Group 3)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 100% ethanol applied in three 30s steps (Group 4)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 100% ethanol applied in one 30s step (Group 5)
Number of subjects: 30
Study: 18585508

Group type: EXPERIMENTAL
Intervention: Abciximab bolus-only (0.25 mg/kg)
Number of subjects: 1005

Group type: COMPARATOR
Intervention: Abciximab bolus + infusion (0.125 microg/[kg min] for 12 hours)
Number of subjects: 1005
Study: 16188769

Group type: EXPERIMENTAL
Intervention: Paediatric care
Number of subjects: 320

Group type: COMPARATOR
Intervention: Primary care
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Both settings
Number of subjects: 320
Study: 12121427

Group type: EXPERIMENTAL
Intervention: One daily bout of walking (Group S1)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Two daily bouts of walking (Group S2)
Number of subjects: 134
Study: 10080677

Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN) - 37 kcal/kg/day + 2.0 g proteins/kg/day for 34 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard Oral Diet (SD)
Number of subjects: 50
Study: 7942245

Group type: EXPERIMENTAL
Intervention: Social influences smoking prevention program
Number of subjects: 100

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 100
Study: 2833577

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, doxorubicin, and cisplatin (CAP)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Vindesine and cisplatin (VP)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Chemotherapy (VP and CAP combined)
Number of subjects: 233
Study: 29169967

Group type: EXPERIMENTAL
Intervention: Lifestyle modification program (telephonic coaching, free of charge)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Noncompliant subjects (less than 78.5% of calls or refused to participate)
Number of subjects: 451
Study: 27776543

Group type: EXPERIMENTAL
Intervention: Local HbA1c measurements
Number of subjects: 255

Group type: COMPARATOR
Intervention: Central HbA1c measurements
Number of subjects: 255
Study: 24962635

Group type: EXPERIMENTAL
Intervention: Gemigliptin 50 mg once daily for 6 days + Glimepiride 4 mg on day 7
Number of subjects: 23

Group type: COMPARATOR
Intervention: Glimepiride 4 mg single dose
Number of subjects: 23
Study: 20524875

Group type: EXPERIMENTAL
Intervention: Glutathione, 500 mg/day for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Glutathione
Number of subjects: 60
Study: 20512260

Group type: EXPERIMENTAL
Intervention: Physiotherapy group (PG) - kinesiotherapy for upper limbs with 19 exercises, 10 rhythmic repetitions or stretching movements.
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (CG) - no physiotherapy.
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Physiotherapy group (PG) - kinesiotherapy for upper limbs.
Number of subjects: 55
Study: 18942124

Group type: EXPERIMENTAL
Intervention: Patients excluded from randomization after PCI
Number of subjects: 343

Group type: COMPARATOR
Intervention: Randomized patients
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Transient vessel closure post-PCI
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Residual dissection >or= grade B post-PCI
Number of subjects: 343
Study: 15824216

Group type: EXPERIMENTAL
Intervention: Verteporfin infusion with reduced fluence (RF) rate (300 mW/cm² for 83 seconds, light dose of 25 J/cm²)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Verteporfin infusion with standard fluence (SF) rate (600 mW/cm² for 83 seconds, light dose of 50 J/cm²)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 117
Study: 12913718

Group type: EXPERIMENTAL
Intervention: Primary plus booster immunizations (6 vaccine doses)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo only
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Primary immunization (3 doses of vaccine)
Number of subjects: 54
Study: 10673872

Group type: COMPARATOR
Intervention: Sevoflurane-nitrous oxide
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Propofol-alfentanil-nitrous oxide
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 44
Study: 8923161

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine (dF) 15 mg bd
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 1352949

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sodium Nitroprusside (SNP)
Number of subjects: 30
Study: 6148025

Group type: EXPERIMENTAL
Intervention: Alfentanil 8 micrograms/kg intravenously prior to induction with etomidate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Halothane as required to maintain adequate anaesthesia
Number of subjects: 50
Study: 31378043

Group type: EXPERIMENTAL
Intervention: Male students
Number of subjects: 2521

Group type: COMPARATOR
Intervention: High peer acceptance
Number of subjects: 2521

Group type: COMPARATOR
Intervention: High family intimacy
Number of subjects: 2521

Group type: COMPARATOR
Intervention: More physical activity
Number of subjects: 2521

Group type: COMPARATOR
Intervention: Mother's education level (junior high school and above)
Number of subjects: 2521

Group type: COMPARATOR
Intervention: Mother's education level (bachelor's degree or above)
Number of subjects: 2521
Study: 29208347

Group type: EXPERIMENTAL
Intervention: Silicone-hydrogel bandage contact lens (BCL)
Number of subjects: 51

Group type: COMPARATOR
Intervention: No bandage contact lens (Control)
Number of subjects: 51
Study: 27260252

Group type: EXPERIMENTAL
Intervention: Mobile communications for exclusive breastfeeding counselling (text messages 2-3 times per week)
Number of subjects: 35
Study: 25340832

Group type: EXPERIMENTAL
Intervention: Ozenoxacin 1% cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Retapamulin 1% ointment
Number of subjects: 0
Study: 22759797

Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil (upper quartile of NT-proBNP)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo (upper quartile of NT-proBNP)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Comparison of least-squares mean difference in 6MWD
Number of subjects: 178
Study: 20082236

Group type: EXPERIMENTAL
Intervention: LEF-anti-TNF-alpha combination therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: MTX-anti-TNF-alpha combination therapy
Number of subjects: 120
Study: 17587447

Group type: EXPERIMENTAL
Intervention: Chemotherapy (specific chemotherapy not detailed)
Number of subjects: 529
Study: 16234514

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, epirubicin, and fluorouracil (CEF); n = 480
Number of subjects: 980

Group type: COMPARATOR
Intervention: Cyclophosphamide, methotrexate, and fluorouracil (CMF); n = 500
Number of subjects: 980
Study: 12049444

Group type: EXPERIMENTAL
Intervention: Parent training (PT) program for preschool ADHD, 8-week duration
Number of subjects: 83
Study: 9856931

Group type: EXPERIMENTAL
Intervention: Less aggressive burst stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher ventricular tachycardia cycle length
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 91% coupling interval
Number of subjects: 0
Study: 8521431

Group type: EXPERIMENTAL
Intervention: Fluoride varnish
Number of subjects: 254

Group type: COMPARATOR
Intervention: Acidulated phosphate fluoride (APF) gel
Number of subjects: 254
Study: 2191587

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 53

Group type: COMPARATOR
Intervention: Altizide + Spironolactone
Number of subjects: 53
Study: 365429

Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study: 31148344

Group type: EXPERIMENTAL
Intervention: Pharmacists' training on pharmacovigilance
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Pharmacists' beliefs about synthetic drugs
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Pharmacists' beliefs about natural drugs
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Pharmacists' opinions on reporting adverse reactions of natural drugs
Number of subjects: 422
Study: 28706166

Group type: EXPERIMENTAL
Intervention: Instructional coaching program (8 sessions of 60 minutes each)
Number of subjects: 70
Study: 26536871

Group type: COMPARATOR
Intervention: Paclitaxel (PTX) alone (80 mg/m², d1; n=47)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Iniparib plus weekly Paclitaxel (PWI) (11.2 mg/kg, d1; n=46)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Iniparib plus twice-weekly Paclitaxel (PTI) (5.6 mg/kg, d1, 4; n=48)
Number of subjects: 141
Study: 24400341

Group type: EXPERIMENTAL
Intervention: Exercise training & Alagebrium (200 mg/day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Exercise training & placebo
Number of subjects: 48

Group type: COMPARATOR
Intervention: No exercise training & Alagebrium (200 mg/day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No exercise training & placebo
Number of subjects: 48
Study: 21501129

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 180

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 180
Study: 19304990

Group type: EXPERIMENTAL
Intervention: Body surface area (BSA) at age 20, midlife BMI, and weight gain from age 20 to midlife
Number of subjects: 6903

Group type: EXPERIMENTAL
Intervention: Weight gain from age 20 to midlife
Number of subjects: 6903
Study: 16984235

Group type: EXPERIMENTAL
Intervention: rhIGF‐I/IGFBP‐3 complex (SomatoKine) 0.4 mg/kg/day
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 15533733

Group type: EXPERIMENTAL
Intervention: Valsartan (80 mg once daily)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Nifedipine coat-core (20 mg once daily)
Number of subjects: 41
Study: 11684410

Group type: EXPERIMENTAL
Intervention: Same Size (100 kcal)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Small Liquid Meal (100 kcal)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Standard Meal (847 kcal)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fasted Phase
Number of subjects: 12
Study: 9290963

Group type: EXPERIMENTAL
Intervention: Combination of rifampicin 600 mg plus ofloxacin 400 mg plus minocycline 100 mg (ROM) administered as single dose
Number of subjects: 1483

Group type: COMPARATOR
Intervention: Standard six-month WHO/MDT/PB regimen
Number of subjects: 1483
Study: 8300461

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate inhaler (50 ug) 2 puffs qds
Number of subjects: 44

Group type: COMPARATOR
Intervention: Salbutamol inhaler (100 mcg) 2 puffs tds
Number of subjects: 44
Study: 3572629

Group type: EXPERIMENTAL
Intervention: Formula B (3.6 g/kg/d protein, 115 kcal/kg/d energy)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Formula C (3.5 g/kg/d protein, 149 kcal/kg/d energy)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Formula A (2.24 g/kg/d protein, 113 kcal/kg/d energy)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Formula B vs Formula A
Number of subjects: 19

Group type: COMPARATOR
Intervention: Formula C vs Formula B
Number of subjects: 19

Group type: COMPARATOR
Intervention: Formula A and C
Number of subjects: 19
Study: 29096069

Group type: EXPERIMENTAL
Intervention: Circuit exercise training (3 times a week, 45-90 min, intensity 50%-90% peak oxygen uptake for 4 weeks)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Circuit exercise training (3 times a week, 45-90 min, intensity 50%-90% peak oxygen uptake for 8 weeks)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Circuit exercise training (4 weeks and 8 weeks)
Number of subjects: 70
Study: 26323598

Group type: EXPERIMENTAL
Intervention: rs9346455
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: rs7336345
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: rs1012650
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: rs1059778
Number of subjects: 189
Study: 24705232

Group type: EXPERIMENTAL
Intervention: Oral clonidine (0.2 mg) administered 2 hours before anesthesia
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 22760531

Group type: EXPERIMENTAL
Intervention: Delayed antimicrobial treatment with amoxicillin‐clavulanate for 7 days
Number of subjects: 214

Group type: COMPARATOR
Intervention: Immediate antimicrobial treatment with amoxicillin‐clavulanate for 7 days
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Delayed antimicrobial treatment
Number of subjects: 214
Study: 20101114

Group type: EXPERIMENTAL
Intervention: Extracellular matrix
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moist wound dressing
Number of subjects: 0
Study: 18039674

Group type: EXPERIMENTAL
Intervention: Complete abstinence from alcohol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Any drinking
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Positive %CDT (> or =2.6)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Positive GGT (> or =50 IU)
Number of subjects: 120
Study: 17209507

Group type: EXPERIMENTAL
Intervention: Ramipril 15 mg/day
Number of subjects: 5269

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 8 mg/day
Number of subjects: 5269

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5269
Study: 12488380

Group type: EXPERIMENTAL
Intervention: i.v. amino acid infusion (4 kJ kg(‐1) h(‐1) starting 2 h before surgery)
Number of subjects: 35

Group type: COMPARATOR
Intervention: saline infusion
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: i.v. amino acid infusion
Number of subjects: 35
Study: 10625579

Group type: EXPERIMENTAL
Intervention: Topical analgesia cream (EMLA)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo and untreated areas
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cooling (all treatments)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Pin-pricking (all treatments)
Number of subjects: 11
Study: 8858057

Group type: EXPERIMENTAL
Intervention: Riluzole
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1100
Study: 1536784

Group type: EXPERIMENTAL
Intervention: Active treatment with traditional Chinese medicinal plants for 8 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 47
Study: 6492228

Group type: EXPERIMENTAL
Intervention: Activated charcoal (10 g) with acetaminophen (1 g)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Activated charcoal (10 g) with sodium sulfate (18 g) and acetaminophen (1 g)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sodium sulfate (18 g) with acetaminophen (1 g)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Acetaminophen (1 g) alone
Number of subjects: 8
Study: 31827687

Group type: EXPERIMENTAL
Intervention: Active PBMT
Number of subjects: 22
Study: 28626088

Group type: EXPERIMENTAL
Intervention: Achieved all 5 secondary prevention parameters
Number of subjects: 13616

Group type: EXPERIMENTAL
Intervention: Achieved at least 4 secondary prevention parameters
Number of subjects: 13616

Group type: EXPERIMENTAL
Intervention: Blood pressure control
Number of subjects: 13616

Group type: EXPERIMENTAL
Intervention: Nonsmoking status
Number of subjects: 13616

Group type: EXPERIMENTAL
Intervention: Higher baseline secondary prevention score
Number of subjects: 13616
Study: 27020585

Group type: EXPERIMENTAL
Intervention: PHH3 mitotic count
Number of subjects: 100

Group type: COMPARATOR
Intervention: H&E mitotic count
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ki67 labeling index (Ki67LI)
Number of subjects: 100
Study: 25403147

Group type: EXPERIMENTAL
Intervention: Symptoms first strategy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Key first strategy
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both strategies
Number of subjects: 51
Study: 23422800

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic lobectomy (VATS)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional lobectomy (thoracotomy)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Univariate analysis
Number of subjects: 65
Study: 19262392

Group type: EXPERIMENTAL
Intervention: Scalp block with 20 ml 0.5% bupivacaine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Infiltration anaesthesia with 0.5% bupivacaine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Routine anaesthesia (Control group) with opioids
Number of subjects: 45
Study: 17161125

Group type: EXPERIMENTAL
Intervention: Hypnosis (including analgesia suggestions 20 min before and throughout the surgical procedure)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (hypnosis and control)
Number of subjects: 30
Study: 15277915

Group type: COMPARATOR
Intervention: Hemofiltration
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control (Saline)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Steroid
Number of subjects: 192
Study: 11915634

Group type: EXPERIMENTAL
Intervention: New injection system
Number of subjects: 14

Group type: COMPARATOR
Intervention: Compression-pack technique
Number of subjects: 14